Source: MarketScreener

Sterigenics: Sterigenics Issues Statement on Favorable Verdict in Fornek Trial

(marketscreener.com) OAK BROOK, Ill., Nov. 21, 2022 -- In response to numerous inquiries, Sterigenics®, a business of Sotera Health , and a global leader in comprehensive sterilization services, today issued the following statement regarding the verdict in favor of the Company in the Fornek trial: "On November 18, 2022, the Fornek trial concluded, and...https://www.marketscreener.com/quote/stock/SOTERA-HEALTH-COMPANY-115501540/news/Sterigenics-Issues-Statement-on-Favorable-Verdict-in-Fornek-Trial-42379095/?utm_medium=RSS&utm_content=20221121

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Michael Rutz's photo - President of Sterigenics

President

Michael Rutz

CEO Approval Rating

82/100

Read more